Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: A case series

Journal of Interventional Cardiology

Volumn 14, Issue 2, 2001, Pages 179-186

  Hooman, Madyoon ^a   Linda, Croushore ^a  

^a St Joseph's Medical Center Stockton   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FENOLDOPAM;

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; CASE REPORT; FEMALE; HEART CATHETERIZATION; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS;

EID: 0035005218     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2001.tb00731.x     Document Type: Article

References (26)

1. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: A prospective trial
2. Contrast medium-induced acute renal failure
3. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography
4. Nephrotoxicity of contrast media (clinical conference)
5. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
6. The effect of acute renal failure on mortality: A cohort analysis
7. Outcomes and cost effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. Study to Understand prognoses and preferences for outcomes and risks of treatments
8. Economic cost of ESRD and Medicare spending by modality in Excerpts from United States Renal Data system 1999 annual data report
9. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents
10. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans
11. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency
12. Nephrotoxicity of high osmolality versus low osmolality contrast media: Randomized clinical trial
13. Effects of high and low osmolar contrast media on renal plasma flow and glomerular filtration rate in euvolaemic and dehydrated rats: A comparison between ioxithalamate, iopamidol, iohexol and ioxaglate
14. Blood flow distribution during controlled hypotension induced by fenoldopam in anesthetized dogs
15. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
16. Contrast medium-associated nephropathy: Recognition and management
17. Use of fenoldopam to prevent radiocontrast nephropathy (RCN) in high-risk patients
18. Fenoldopam: A dopamine type 1 receptor agonist in the prevention of renal injury associated with the administration of intravascular contrast
19. Prophylactic efficacy of fenoldopam in radiocontrast nephropathy (RCN): A randomized, doubleblind, placebo-controlled trial
20. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
21. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status
22. Renal and systemic effects of very low-dose fenoldopam in normotensive subjects
23. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics
24. Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine 1 agonist fenoldopam
25. Therapeutics for hypertensive urgencies and emergencies: Fenoldopam, a novel systemic and renal vasodilator